Category: Decentralized Clinical Trials
Auto Added by WPeMatico
AI and Decentralized Trials: A New Era in Drug Development
AI and Decentralized Trials: A New Era in Drug Development The following is a guest article by Matt Noble, Head…
Q/A: Medidata VP Talks Overcoming Financial Barriers to Diversity in Clinical Trials
Q/A: Medidata VP Talks Overcoming Financial Barriers to Diversity in Clinical Trials Meghan Harrison, VP of Clinical Trial Financial Management…
How A Human-AI Partnership Can Boost Clinical Trial Recruitment
How A Human-AI Partnership Can Boost Clinical Trial Recruitment The demand for clinical trial testing is rising, from over 260,000 trials conducted…
Expectations For The Connected Care Business In The Years Ahead
Expectations For The Connected Care Business In The Years Ahead Russ Johannesson, CEO at Glooko Though we seldom see their…
ObvioHealth Launches Decentralized Clinical Trial for Migraine Treatment Device
ObvioHealth Launches Decentralized Clinical Trial for Migraine Treatment Device What You Should Know: – ObvioHealth and Mi-Helper, Inc. announce a partnership…
ObvioHealth Launches Decentralized Clinical Trial for Migraine Treatment Device
ObvioHealth Launches Decentralized Clinical Trial for Migraine Treatment Device What You Should Know: – ObvioHealth and Mi-Helper, Inc. announce a partnership…
H1 Launches Advanced Diversity and Clinical Trial Performance Insights
H1 Launches Advanced Diversity and Clinical Trial Performance Insights What You Should Know: – H1, the connecting force for global…
Report: Pharma R&D ROI Falls to Lowest Level in 13 Years
Report: Pharma R&D ROI Falls to Lowest Level in 13 Years What You Should Know: – Deloitte Centre for Health…
Executives Shares 7 Life Sciences Predictions to Watch in 2023
Executives Shares 7 Life Sciences Predictions to Watch in 2023 Tracy Curley, CFO and interim CEO at iSpecimen Focusing on…
Executives Shares 7 Life Sciences Predictions to Watch in 2023
Executives Shares 7 Life Sciences Predictions to Watch in 2023 Tracy Curley, CFO and interim CEO at iSpecimen Focusing on…
